SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 48 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $265,000 | -4.7% | 212,000 | 0.0% | 0.00% | – |
Q1 2022 | $278,000 | -94.9% | 212,000 | -94.3% | 0.00% | -100.0% |
Q4 2021 | $5,419,000 | -56.9% | 3,700,000 | -56.5% | 0.00% | -66.7% |
Q3 2021 | $12,570,000 | +144.5% | 8,500,000 | +117.9% | 0.01% | +200.0% |
Q2 2021 | $5,141,000 | +45.8% | 3,900,000 | +129.4% | 0.00% | 0.0% |
Q3 2020 | $3,525,000 | -23.2% | 1,700,000 | -15.0% | 0.00% | -33.3% |
Q2 2020 | $4,590,000 | +75.3% | 2,000,000 | +0.9% | 0.00% | +50.0% |
Q3 2019 | $2,618,000 | -50.7% | 1,982,000 | -17.0% | 0.00% | -33.3% |
Q2 2019 | $5,313,000 | +5.8% | 2,387,000 | -14.2% | 0.00% | 0.0% |
Q1 2019 | $5,021,000 | – | 2,783,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 53,865,000 | $101,127,280 | 3.93% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,657,000 | $165,397,613 | 3.42% |
Boussard & Gavaudan Investment Management LLP | 11,898 | $21,871,538 | 2.42% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 38,394,000 | $71,834,226 | 1.71% |
WOLVERINE ASSET MANAGEMENT LLC | 79,876,000 | $149,367,384 | 1.55% |
CSS LLC/IL | 4,747,000 | $8,868,606 | 0.50% |
Opti Capital Management, LP | 3,000,000 | $5,611,938 | 0.48% |
Verition Fund Management LLC | 16,459,000 | $30,786,560 | 0.48% |
Aequim Alternative Investments LP | 5,000,000 | $9,352,500 | 0.25% |
MIZUHO SECURITIES USA LLC | 1,097,000 | $2,047,616 | 0.19% |